Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream -April 01, 2024 at 07:00 am EDT

NESS ZIONA, Israel, April 01, 2024 -- Sol-Gel Technologies, Ltd. , a dermatology company pioneering treatments for patients with severe skin conditions, conducting a Phase 3 clinical trial of...

Related Keywords

Canada ,United States ,New Jersey ,Israel ,Mori Arkin ,Gilad Mamlok ,Gel Technologies Ltd ,Nasdaq ,Drug Administration ,Arcutis Biotherapeutics Inc ,Us District Court ,Exchange Commission ,Padagis Israel Pharmaceuticals Ltd ,Globenewswire Inc ,Company Annual Report On Form ,Gel Technologies ,Israel Pharmaceuticals Ltd ,Abbreviated New Drug Application ,Roflumilast Cream ,Padagis Roflumilast Cream ,Zoryve Cream ,Executive Chairman ,Private Securities Litigation Reform Act ,Annual Report ,Gel Contact ,Sol Gel Technologies ,